Provider Tools

Recommended resources from across the SRH field
Showing 26-33 of 74 results

Research roundup: October 2023 edition

Pain management in abortion care, risk of Rh sensitization with abortion before 12 weeks’ gestation, and contraception information on TikTok.

Research roundup: September 2023 edition

Patients' preferences for contraceptive educational materials, management of missing IUD strings and migrated IUDs, and providers’ perspectives on how to improve contraceptive counseling.

Research roundup: August 2023 edition

COX-2 inhibitor demonstrates potential in increasing efficacy of OTC LNG-EC pills; updated systematic review and meta-analysis supporting the effectiveness and safety of misoprostol-alone for medication abortion; support needs of adolescents and young adult abortion seekers; and more!

Research roundup: July 2023 edition

Continued support for misoprostol-only regimens for medication abortion and self-managed abortion between nine and 16 weeks gestation, the use of home pregnancy tests for follow-up care after a telehealth medication abortion, where adolescents and young adults go online to get abortion information, and disparities in recommended retesting for women with trichomonas vaginalis infections.

Research roundup: June 2023 edition

Men’s willingness to use novel birth control, characteristics of patients seeking telehealth medication abortion care, mifepristone as a potential treatment for adenomyosis, and the impact of the pill on adolescent bone health.

Research roundup: May 2023 edition

Initial reports from the ongoing narrative collection Care Post Roe documenting poor-quality care, patient perspectives on telehealth medication abortion, adolescent preferences and experiences with pregnancy options counseling, and more.

Research roundup: April 2023 edition

Perceived pain and sedation dosing during abortion procedures by demographics, PAPP-A as a novel screening for gestational age before medication abortion, patient experiences with progestin-only pills and attitudes towards OTC access.
  • Previous
  • 2
  • 3
  • 4(current)
  • 5
  • 6
  • Next